OPKO Health Inc OPK:NASDAQ

Last Price$1.71Cboe Real-Time Last Sale as of 9:31AM ET 1/23/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.02(1.16%)
Bid (Size)$1.70 (1,300)
Ask (Size)$1.71 (1,310)
Day Low / High$1.71 - 1.71
Volume95.4 K
 

View Biotechnology IndustryPeer Comparison as of 01/23/2020

 

OPKO Health Inc ( NASDAQ )

Price: $1.71
Change: -0.02 (1.16%)
Volume: 95.4 K
9:31AM ET 1/23/2020
 
 

Rocket Pharmaceuticals Inc ( NASDAQ )

Price: $20.96
Change: -0.36 (1.69%)
Volume: 2.00
9:30AM ET 1/23/2020
 
 

Enanta Pharmaceuticals Inc ( NASDAQ )

Price: $56.99
Change: +0.01 (0.02%)
Volume: 499.7 K
3:59PM ET 1/22/2020
 
 

NGM Biopharmaceuticals Inc ( NASDAQ )

Price: $18.10
Change: +0.01 (0.06%)
Volume: 110.00
3:59PM ET 1/22/2020
 
 

Karyopharm Therapeutics Inc ( NASDAQ )

Price: $16.98
Change: -0.24 (1.39%)
Volume: 79.00
9:31AM ET 1/23/2020
 

Read more news Recent News

Wall Street Sees Cautiously Lower Open on Virus Outbreak Concerns
33 minutes ago, 9:00AM ET 1/23/2020 MT Newswires

US stocks were set for a cautiously lower open Thursday as investors continued to assess the potential threat from the new, deadly strain of coronavirus...

Opko Health Soars on CEO Comments on Growth Hormone Therapy Candidate Somatrogon
2:46PM ET 1/22/2020 MT Newswires

Opko Health (OPK) shares climbed 11% in afternoon trade after Chief Executive Phillip Frost's positive comments on the company's growth hormone deficiency...

Insider Trends: Insider Buying Continued with Purchase of OPKO Health Stock
8:16AM ET 12/31/2019 MT Newswires

Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, on Dec 30, 2019, made a purchase of 100,000 shares in OPKO Health (OPK) for $146,000. Dr Frost...

Insider Trends: Insider Buying Continued with Purchase of OPKO Health Stock
7:46AM ET 12/30/2019 MT Newswires

Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, on Dec 27, 2019, executed a purchase for 100,000 shares in OPKO Health (OPK) for $152,500. Dr...

View all Commentary and Analysis

Daily Insider Ratings Round Up 1/13/20
8:57PM ET 1/14/2020 Seeking Alpha

Daily Insider Ratings Round Up 1/9/20
5:04PM ET 1/14/2020 Seeking Alpha

OPKO Health: The Fallen Bird
1:31PM ET 1/08/2020 Seeking Alpha

Insider Weekends: A Lost Decade Of Insider Buying By Dr. Frost
9:04AM ET 1/06/2020 Seeking Alpha

Company Profile

Business DescriptionOPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. View company web site for more details
Address4400 Biscayne Boulevard
Miami, Florida 33137
Phone+1.305.575.4100
Number of Employees5,690
Recent SEC Filing01/21/20204
Chairman & Chief Executive OfficerPhillip Frost
Chief Financial Officer & Senior Vice PresidentAdam E. Logal
Vice Chairman & Chief Technical OfficerJane H. Hsiao
Director & Executive Vice President-AdministrationSteven D. Rubin

Company Highlights

Price Open$1.71
Previous Close$1.73
52 Week Range$1.33 - 3.87
Market Capitalization$1.1 B
Shares Outstanding665.6 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/26/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.48
Beta vs. S&P 500N/A
Revenue$990.3 M
Net Profit Margin-30.98%
Return on Equity-16.14%

Analyst Ratings as of 12/17/2019

Buy
4
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset